Document is current
Any future updates will be listed below
-
Authors
Han, Alexander L. https://orcid.org/0000-0002-2516-2343
Sands, Chloe F.
Matelska, Dorota
Butts, Jessica C.
Ravanmehr, Vida
Hu, Fengyuan
Villavicencio Gonzalez, Esmeralda
Katsanis, Nicholas
Bustamante, Carlos D.
Wang, Quanli
Petrovski, Slavé https://orcid.org/0000-0002-1527-961X
Vitsios, Dimitrios https://orcid.org/0000-0002-8939-5445
Dhindsa, Ryan S. https://orcid.org/0000-0002-8965-0813
-
Funding
Funding for this research was provided by:
Impetus Grant from Norn Group, Hevolution Foundation, and Rosenkranz Foundation.
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 5 March 2025
First Online: 18 March 2025
Competing interests
: D.M., F.H., Q.W., S.P., and D.V. are current employees and/or stockholders of AstraZeneca. R.S.D. is a paid consultant of AstraZeneca. N.K. and C.D.B. are employees of Galatea Bio. The remaining authors declare no competing interests.
